|Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America|
JR Perfect, WE Dismukes, F Dromer, DL Goldman, JR Graybill, RJ Hamill, ...
Clinical infectious diseases 50 (3), 291-322, 2010
|Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK|
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
T Bicanic, TS Harrison
British medical bulletin 72 (1), 99-118, 2004
|Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial|
AE Brouwer, A Rajanuwong, W Chierakul, GE Griffin, RA Larsen, ...
The Lancet 363 (9423), 1764-1767, 2004
|Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …|
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
|High-dose rifapentine with moxifloxacin for pulmonary tuberculosis|
A Jindani, TS Harrison, AJ Nunn, PPJ Phillips, GJ Churchyard, ...
N Engl J Med 371, 1599-1608, 2014
|Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa|
JN Jarvis, SD Lawn, M Vogt, N Bangani, R Wood, TS Harrison
Clinical Infectious Diseases 48 (7), 856-862, 2009
|Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or …|
T Bicanic, G Meintjes, R Wood, M Hayes, K Rebe, LG Bekker, T Harrison
Clinical infectious diseases 45 (1), 76-80, 2007
|HIV-associated cryptococcal meningitis|
JN Jarvis, TS Harrison
Aids 21 (16), 2119-2129, 2007
|Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis|
JN Jarvis, A Percival, S Bauman, J Pelfrey, G Meintjes, GN Williams, ...
Clinical Infectious Diseases 53 (10), 1019-1023, 2011
|Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes|
JN Jarvis, T Bicanic, A Loyse, D Namarika, A Jackson, JC Nussbaum, ...
Clinical infectious diseases 58 (5), 736-745, 2014
|Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages|
GM Cox, TS Harrison, HC McDade, CP Taborda, G Heinrich, ...
Infection and immunity 71 (1), 173-180, 2003
|Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases|
JN Jarvis, G Meintjes, A Williams, Y Brown, T Crede, TS Harrison
BMC infectious diseases 10 (1), 1-6, 2010
|High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial|
T Bicanic, R Wood, G Meintjes, K Rebe, A Brouwer, A Loyse, LG Bekker, ...
Clinical infectious diseases 47 (1), 123-130, 2008
|Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy|
PR Williamson, JN Jarvis, AA Panackal, MC Fisher, SF Molloy, A Loyse, ...
Nature Reviews Neurology 13 (1), 13, 2017
|Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages|
SM Levitz, SH Nong, KF Seetoo, TS Harrison, RA Speizer, ER Simons
Infection and immunity 67 (2), 885-890, 1999
|Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.|
JN Jarvis, G Meintjes, K Rebe, GN Williams, T Bicanic, A Williams, ...
AIDS (London, England) 26 (9), 1105, 2012
|Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution|
T Bicanic, T Harrison, A Niepieklo, N Dyakopu, G Meintjes
Clinical infectious diseases 43 (8), 1069-1070, 2006
|Fungal infections in HIV/AIDS|
AH Limper, A Adenis, T Le, TS Harrison
The Lancet Infectious Diseases 17 (11), e334-e343, 2017
|Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda|
N Longley, C Muzoora, K Taseera, J Mwesigye, J Rwebembera, ...
Clinical infectious diseases 47 (12), 1556-1561, 2008